Patent ID: 11903974
Assignee: FLAGSHIP PIONEERING INNOVATIONS V, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G | IPC A  C  G

Claim 18:
19. The method of claim 1, wherein the cultured cells are one or more of: a mammalian cell line, a human cell line, a mammalian cell strain, a human cell strain, cells in suspension, adherent cells, a primary cell culture, a primary human cell culture, cultured progenitor cells, epithelial cells, bone marrow cells, skeletal cells, neural cells, cardiomyocytes, induced pluripotent stem cells (iPS cells), bone marrow stromal cells, marrow-derived adult progenitor cells (MAPCs), endothelial progenitor cells (EPC), blast cells, intermediate progenitor cells formed in the subventricular zone, neural stem cells, muscle stem cells, satellite cells, liver stem cells, hematopoietic stem cells, bone marrow stromal cells, epidermal stem cells, embryonic stem cells, mesenchymal stem cells, umbilical cord stem cells, precursor cells, muscle precursor cells, myoblast, cardiomyoblast, neural precursor cells, glial precursor cells, neuronal precursor cells, adipose cells, brown adipose cells, or hepatoblasts.